In the last module, we learned about the historical and legal context as well as some foundational aspects about the molecular structure of ketamine. In this module, we will be looking at ketamine’s pharmacodynamics or, in other words, the effects that ketamine has on the body as well as the pharmacokinetics, or how ketamine is absorbed and metabolized by the body. We will explore the indications that ketamine-assisted therapy seeks to treat, the mechanisms of actions, and the dose ranges of ketamine.
In the last module, we learned about the historical and legal context as well as some foundational aspects about the molecular structure of ketamine. In this module, we will be looking at ketamine’s pharmacodynamics or, in other words, the effects that ketamine has on the body as well as the pharmacokinetics, or how ketamine is absorbed and metabolized by the body. We will explore the indications that ketamine-assisted therapy seeks to treat, the mechanisms of actions, and the dose ranges of ketamine.
Upon successful completion of the course, you will be able to:
Explain the risks, benefits, and pharmacological knowledge of ketamine in plain language to interdisciplinary colleagues and to clients as part of the informed consent process.
Describe recommended dosages, expected duration, metabolism, and expected intensity of ketamine.
Identify key areas of research on ketamine.
Explain the pharmacodynamics and pharmacokinetics of ketamine.
Describe the subjective and physiological effects and adverse effects of ketamine according to different dose ranges as they relate to psychedelic-assisted therapy.
Explain the primary effects and mechanisms of action of ketamine on the brain, including connectivity in the brain and activation of serotonin receptors.
Explain for which indications ketamine is used.